Neuroendocrine pathways of addictive behaviour

Addiction Biology

Volumn 9, Issue 3-4, 2004, Pages 205-212

  Kiefer, Falk ^a   Wiedemann, K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ATRIAL NATRIURETIC FACTOR; BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID RECEPTOR; LEPTIN; LEPTIN RECEPTOR; METYRAPONE; PLACEBO;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL MODEL; ANXIETY; BEHAVIOR; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DETOXIFICATION; DRINKING BEHAVIOR; FOREBRAIN; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; MOUSE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE; REVIEW;

ALCOHOLISM; ANIMALS; ATRIAL NATRIURETIC FACTOR; BETA-ENDORPHIN; CORTICOTROPIN-RELEASING HORMONE; ETHANOL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEPTIN; PITUITARY-ADRENAL SYSTEM; RECURRENCE; STATISTICS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 8544275817     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210412331292532     Document Type: Review

References (57)

1. Jenkins JS, Connolly J. Adrenocortical response to ethanol in man. Br Med J 1968;2:804-5.
2. Brady KT, Sonne SC. The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Res Health 1999;23:263-71.
3. Bell SM, Reynolds JG, Thiele TE, Gan J, Figlewicz DP, Woods SC. Effects of third intracerebroventricular injections of corticotrophin-releasing factor (CRF) on ethanol drinking and food intake. Psychopharmacology 1998;139:128-35.
4. Olive MF, Mehmert KK, Koenig HN, et al. A role for corticotrophin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice. Psychopharmacology 2003;165:181-7.
5. Sillaber I, Rammes G, Zimmermann S, et al. Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 2002;296:931-3.
6. Winkler A, Mahal B, Kiianmaa K, Zieglgansberger W, Spanagel R. Effects of chronic alcohol consumption on the expression of different NR1 splice variants in the brain of AA and ANA lines of rats. Brain Res Mol Brain Res 1999;72:166-75.
7. Holler SM, Danysz W, Spanagel R. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. J Pharmacol Exp Ther 2000;92:45-52.
8. Timpl P, Spanagel R, Sillaber I, et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotrophin-releasing hormone receptor 1. Nat Genet 1998;19:162-6.
9. Ehlers CL, Chaplin RI, Wall TL, et al. Corticotrophin releasing factor (CRF): studies in alcohol preferring and non-preferring rats. Psychopharmacology 1992;106:359-64.
10. Fahlke C, Hard E, Thomasson R, Engel JA, Hansen S. Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats. Pharmacol Biochem Behav 1994;48:977-81.
11. Morin LP, Forger NG. Endocrine control of ethanol intake by rats or hamsters: relative contributions of the ovaries, adrenals and steroids. Pharmacol Biochem Behav 1982;17:529-37.
12. Fahlke C, Engel JA, Eriksson CJ, Hard E, Soderpalm B. Involvement of corticosterone in the modulation of ethanol consumption in the rat. Alcohol 1994;11:195-202.
13. Fahlke C, Eriksson CJ. Effect of adrenalectomy and exposure to corticosterone on alcohol intake in alcohol-preferring and alcohol-avoiding rat lines. Alcohol Alcohol 2000;35:139-44.
14. Lamblin F, De Witte P. Adrenalectomy prevents the development of alcohol preference in male rats. Alcohol 1996;13:233-8.
15. Krishnan S, Maickel RP. The effect of Hoe-427 (an ACTH4-9 analog) on free-choice ethanol consumption in male and female rats. Life Sci 1991;49:2005-11.
16. Fahlke C, Hard E, Hansen S. Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone. Psychopharmacology 1996;127:133-9.
17. Fahlke C, Hansen S. Effect of local intracerebral corticosterone implants on alcohol intake in the rat. Alcohol Alcohol 1999;34:851-61.
18. Fahlke C, Hard E, Eriksson CJ, Engel JA, Hansen S. Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists. Psychopharmacology (Berl) 1995;117:216-24.
19. Cowen MS, Sanchis-Segura C, Cline B, et al. Augmented stress-induced ethanol consumption in mice with neuronal-specific glucocorticoid receptor invitation. Behav Pharmacol 2001;12(suppl. 1):S24.
20. O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek J. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo - pituitary - adrenocortical axis. Psychopharmacology 2002;160:19-29.
21. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-2.
22. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997;138:3859-63.
23. Inui A. Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin. Trends Neurosci 1999;22:62-7.
24. Kiefer F, Jahn H, Wolf K, Kämpf P, Knaudt K, Wiedemann K. Free-choice acohol consumption in mice after appetite regulating peptide leptin. Alcohol Clin Exp Res 2001;25:787-9.
25. Nicolas JM, Fernandez-Sola J, Fatjo F, et al. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res 2001;25:83-8.
26. Kiefer F, Jahn H, Jaschinski M, et al. Leptin: a modulator of alcohol craving? Biol Psychiatry 2001;49:782-7.
27. Kiefer F, Jahn H, Kellner M, Naber D, Wiedemann K. Leptin as a possible modulator of craving for alcohol. Arch Gen Psychiatry 2002;58:509-10.
28. Heinz A, Rommelspacher H, Graf KJ, Kurten I, Otto M, Baumgartner A. Hypothalamic - pituitary - gonadal axis, prolactin, and cortisol in alcoholics during withdrawal and after three weeks of abstinence: comparison with healthy control subjects. Psychiatry Res 1995;56:81-95.
29. Valimaki M, Pelkonen R, Harkonen M, Ylikahri R. Hormonal changes in noncirrhotic male alcoholics during ethanol withdrawal. Alcohol Alcohol 1984;19:235-42.
30. Heuser I, von Bardeleben U, Boll E, Holsboer F. Response of ACTH and cortisol to human corticotrophin-releasing hormone after short-term abstention from alcohol abuse. Biol Psychiatry 1988;24:316-21.
31. Loosen PT, Chambliss B, Pavlou SS, Orth DN. Adrenal function in abstinent alcoholic men. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:771-80.
32. Willenbring ML, Morley JE, Niewoehner CB, Heilman RO, Carlson CH, Shafer RB. Adrenocortical hyperactivity in newly admitted alcoholics: prevalence, course and associated variables. Psychoneuroendocrinology 1984;9:415-22.
33. Merlo Pich E, Lorang M, Yeganeh M, et al. Increase of extracellular corticotrophin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995;15:5439-47.
34. Aguirre JC, Del Arbol JL, Raya J, Ruiz-Requena ME, Rico Irles J. Plasma beta-endorphin levels in chronic alcoholics. Alcohol 1990;7:409-12.
35. Vescovi PP, Coiro V, Volpi R, Giannini A, Passeri M. Plasma beta-endorphin, but not met-enkephalin levels are abnormal in chronic alcoholics. Alcohol Alcohol 1992;27:471-5.
36. Marchesi C, Chiodera P, Brusamonti E, Volpi R, Coiro V. Abnormal plasma oxytocin and beta-endorphin levels in alcoholics after short and long term abstinence. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:797-807.
37. Inder WJ, Livesey JH, Donald RA. Peripheral plasma levels of beta-endorphin in alcoholics and highly trained athletes and the relationship to a measure of central opioid tone. Horm Metab Res 1998;30:523-5.
38. Esel E, Sofuoglu S, Aslan SS, Kula M, Yabanoglu I, Turan MT. Plasma levels of beta-endorphin, adrenocorticotropic hormone and cortisol during early and late alcohol withdrawal. Alcohol Alcohol 2001;36:572-6.
39. Kiefer F, Horntrich M, Jahn H, Wiedemann K. Is withdrawal-induced anxiety in alcoholism based on β-endorphin deficiency? Psychopharmacology 2002;162:433-7.
40. Junghanns K, Backhaus J, Tietz U, et al. Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol 2003;38:189-93.
41. Kiefer F, Jahn H, Tarnaske T, et al. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2003;60:92-9.
42. Kiefer F, Jahn H, Schick M, Wiedemann K. Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship. Psychopharmacology 2002;164:239-40.
43. Antoni FA, Hunter EF, Lowry PJ, Noble JM, Seckl JR. Atriopeptin: an endogenous corticotrophin-release inhibiting hormone. Endocrinology 1992;130:1753-5.
44. Gianoulakis C, Guillaume P, Thavundayil J, Gutkowska J. Increased plasma atrial natriuretic peptide after ingestion of low doses of ethanol in humans. Alcohol Clin Exp Res 1997;21:162-70.
45. Kiefer F, Andersohn F, Jahn H, Wolf K, Raedler TJ, Wiedemann K. Involvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal. Acta Psychiatr Scand 2002;105:65-70.
46. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (EGA) Study. JAMA 1990;264:2511-18.
47. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:13-21.
48. Farrell M, Howes S, Bebbington P, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001;179:432-7.
49. Marshall EJ, Alam F. Psychiatric problems associated with alcohol misuse and dependence. Br J Hosp Med 1997;58:44-6.
50. Haver B. Comorbid psychiatric disorders predict and influence treatment outcome in female alcoholics. Eur Addict Res 2003;9:39-44.
51. Pelc I, Ansoms C, Lehen P, et al. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcohol Clin Exp Res 2002;26:1529-38.
52. Nemeroff CB. The corticotrophin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1996;1:336-42.
53. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotrophin-releasing factor in depression and anxiety disorders. J Endocrinol 1999;160:1-12.
54. Boyer P. Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl 2000;406:24-9.
55. Eriksson M, Fahlke C, Hansen S, Berggren U, Marin P, Balldin J. No effect of the cortisol-synthesis inhibitor metyrapone on alcohol drinking: a pilot study. Alcohol 2001;25:115-22.
56. Menzaghi F, Rassnick S, Heinrichs S, et al. The role of corticotrophin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann NY Acad Sci 1994;739:176-84.
57. Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl.) 2000;150:317-24.